MINNEAPOLIS & TOKYO--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) announced the commercial launch of its latest cardiac resynchronization therapy-defibrillator, the Concerto® CRT-D, and its latest implantable cardioverter-defibrillator, the Virtuoso® ICD. Both devices are the first of their kind in Japan equipped with key features, including wireless telemetry.
